Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the American Thyroid Association's …

Answer questions and earn CME/CNE This is a review of the major changes in the American
Joint Committee on Cancer staging manual, eighth edition, for differentiated and anaplastic …

Differentiated thyroid carcinomas is associated with an excellent prognosis. The treatment of
choice for differentiated thyroid carcinoma is surgery, followed by radioactive iodine ablation …

Background: Sex dimorphism strongly impacts tumor biology, with most cancers having a
male predominance. Uniquely, thyroid cancer (TC) is the only nonreproductive cancer with …

Differentiated thyroid cancers are more frequent in women than in men. These different
frequencies may depend on differences in patient's behavior and in thyroid investigations …

Background: Age is a critical factor in outcome for patients with well-differentiated thyroid
cancer. Currently, age 45 years is used as a cutoff in staging, although there is increasing …

Lipids play critical functions in cellular survival, proliferation, interaction and death, since
they are involved in chemical-energy storage, cellular signaling, cell membranes, and cell …

In many parts of the world, incidence of papillary thyroid cancer is increasing faster than any
other malignancy. Most papillary thyroid cancers that are diagnosed are small and are …

Context: Initial treatments for patients with differentiated thyroid cancer are supported
primarily by single-institution, retrospective studies, with limited follow-up and low event …

BACKGROUND Lenvatinib is an oral, multitargeted tyrosine kinase inhibitor of the vascular
endothelial growth factor receptors 1 through 3 (VEGFR1‐VEGFR3), fibroblast growth factor …